Company / Total Assets
Merck & Co. Total Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$136.9B
FY2025
5-year range
$105.7B / $136.9B
FY2021-FY2025
Trend
+16.9%
vs FY2024
Sector context
#3 of 214
Health Care
What the data says
Among 214 Health Care companies, Merck & Co. is in the top 1% for total assets. Total Assets has fluctuated over the past 10 years, ranging from $82.6B in FY2018 to $136.9B in FY2025.
Based on SEC 10-K filings.
$136.9B in FY2025 with a 5-year CAGR of +8.4%. Ranks 3rd among 214 companies in Health Care.
Improved from $106.7B to $136.9B over the past 2 years.
Health Care sector context is included.
Total Assets over time
Growth rates
- 3-Year CAGR
- +7.8%
- 5-Year CAGR
- +8.4%
- 10-Year CAGR
- -
Sector benchmark
Top 1% in Health CareTop 1% of 214This company $136.9B Sector average $7.5B
▼
+1732.3% above sector average
Key checks
Key Insights
- 5-year CAGR of +8.4%, indicating consistent growth.
- In FY2025, total assets increased 16.9% year-over-year.
- Ranks #3 out of 214 companies in the Health Care sector.
- Lowest total assets in the period was in FY2018.
Company context
Key Data Points
- Strong profit margin: 29.6%
- Strong return on equity: 36.7%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $136.9B | +16.9% |
| FY2024 | $117.1B | +9.8% |
| FY2023 | $106.7B | -2.3% |
| FY2022 | $109.2B | +3.3% |
| FY2021 | $105.7B | +15.4% |
| FY2020 | $91.6B | +8.5% |
| FY2019 | $84.4B | +2.1% |
| FY2018 | $82.6B | -6.0% |
| FY2017 | $87.9B | -7.9% |
| FY2016 | $95.4B | -6.2% |
As of FY2025 · SEC 10-K · Updated Mar 9, 2026